Es befinden sich keine Waren im Warenkorb !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Start > IgG


Brief Information

Name:Immunoglobulin G
Target Synonym:Immunoglobulin G
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Approved

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data


Immobilized Human ACE2 Protein, Fc Tag (Cat. No. AC2-H5257) at 2μg/mL (100μL/well) can bind Monoclonal Anti-Human-IgG-Fc Antibody,Mouse IgG1 (6F11C8) (HPLC verified) (Cat. No. IGG-AY69) with a linear range of 0.10-3.13 ng/mL (QC tested).

IgG MALS images

The purity of Anti-Human IgG Antibody-Acridinium ester (Cat. No. AHG-Y69) is more than 90% and the molecular weight of this protein is around 140-170 kDa verified by SEC-MALS.

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Imlifidase Mac-1 Approved Hansamed Inc Idefirix EU Rejection of renal transplantation Hansa Biopharma Ab 2020-08-25 Rejection of renal transplantation; Purpura, Thrombotic Thrombocytopenic; Kidney Diseases; Rejection of organ transplantation; Guillain-Barre Syndrome; Renal Insufficiency, Chronic; Kidney Failure, Chronic Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Recombinant Tumor Enzyme Specific Interferon α-2b Fc Fusion (Livzon Pharmaceutical Group) A-01 Phase 1 Clinical Livzon Pharmaceutical Group Inc Solid tumours Details
Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD) Phase 1 Clinical University Of California San Diego Leukemia, Myeloid, Acute Details
AT-02 AT-02 Phase 1 Clinical Attralus Inc Immunoglobulin Light-chain Amyloidosis; Amyloidosis Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
Lichtstrasse 35,4056 Basel, Switzerland

Nachricht schicken